Adelman Agliano & Boothby Pa Tampa, FL - 33603

Adelman Agliano & Boothby Pa is categorized under Ear Nose and Throat Doctors in Tampa, FL and active since 1971.

Adelman Agliano & Boothby Pa was established in 1971, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Ear Nose and Throat Doctors business, which does work in the B2C market, and is classified as a Ear Nose and Throat Doctors, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Martin J Adelman at the company’s single location by writing to 5105 North Armenia Avenue, Tampa, Florida FL 33603 or by phoning (813) 879-8045. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Adelman Agliano & Boothby Pa
Contact Person: Martin J Adelman
Address: 5105 North Armenia Avenue, Tampa, Florida 33603
Phone Number: (813) 879-8045
Annual Revenue (USD): $500.000 to $999.999
Founded: 1971
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Ear Nose and Throat Doctors
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Adelman Agliano & Boothby Pa was started in 1971 to provide professional Ear Nose and Throat Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Martin J Adelman for inquiries that concern Adelman Agliano & Boothby Pa by calling the company number (813) 879-8045, as your correspondence is most welcome. Additionally, the physical location of the single location of Adelman Agliano & Boothby Pa can be found at the coordinates 27.992534,-82.484321 as well as the street address 5105 North Armenia Avenue in Tampa, Florida 33603.

For its online presence, you may visit Adelman Agliano & Boothby Pa’s website at and engage with its social media outlets through on Twitter and on Facebook.